Mesa Laboratories, Inc. · NASDAQ:MLAB
Mesa Laboratories — Investor Presentation (August 2015)
19 slides from Mesa Laboratories's investor presentation, Aug 23, 2015
Slide 1: Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Key Contacts: John Sullivan, President and CEO John Sakys, VP Finance and CFO InvestorRelations@mesalabs.com Phone – 303-987-8000 NASDAQ: MLAB
Slide 2: Safe Harbor Statement
Safe Harbor Statement The information provided in this presentation contains forward-looking statements within the meaning of the federal securities laws. These forward looking statements include, among others, statements regarding operating results, the success of our internal operating plans and t
Slide 3: Mesa at a Glance
Mesa at a Glance Manufacturer of Instruments and Consumables for Quality Control “MLAB” on the NASDAQ FY2015 Revenues of $71.3M ~$400M Market Cap Gross Profit Margin over 60% Founded in 1982, Public in Adjusted Net Income of 18% 1984 ~330 Employees Revenues by Division Revenues by Sour
Slide 4: Mesa at a Glance
Mesa at a Glance Manufacturing / Laboratories Lakewood, Colorado (HQ) Sales and Customer Support Bozeman, Montana Marlton, New Jersey Omaha, Nebraska Lyon, France Traverse City, Michigan Butler, New Jersey Markham, Ontario 4
Slide 5: Mesa's Growth Strategy: Our Focus
Mesa’s Growth Strategy Our Focus Provide high-value, high-quality products and services to selected niche markets Focus on technology and markets that result in above-average profitability Win the loyalty of our customers by being the most responsive and most flexible company in the markets we
Slide 6: Mesa's Growth Strategy: Our Tactics
Mesa’s Growth Strategy Our Tactics Improve our distribution channels Increase flow of new products Build a winning team Create infrastructure to support our high growth rate Promote flexible, metric-driven manufacturing operations Continue locating and closing strategic acquisitions 6
Slide 7: Mesa's Growth Strategy: Our 5-Year Financial Goals
Mesa’s Growth Strategy Our 5-Year Financial Goals Continue 10% to 20% annual revenues growth Maintain adjusted net income near 20% of revenues Achieve annual organic revenues growth of greater than 5% Maintain cash flow levels adequate to support our acquisition program 7
Slide 8: Mesa's Growth Strategy: Our Acquisitions
Mesa’s Growth Strategy Our Acquisitions North Bay Infitrak PCD 3 BI Dist. 2016 BGI Amilabo 2015 Amega - Tempsys Suretorque 2014 Bios Apex 2013 SGM Biotech Cold Chain Torqo Raven Instruments 2009 Biological Indicators Automata Nusonics 2004 Continuous Monitoring DataTrace Western 1994 8 1984
Slide 9: Products: Instruments Division
Mesa’s Products Instruments Division Markets • Dialysis Clinics and Manufacturing • Pharmaceutical and Medical Device Dialysis Meters Data Loggers • Food and Beverage • Industrial Hygiene Gas Flow • Semiconductor Calibration Manufacturing • Metrology Laboratories • Environmental Testing Cap Torque T
Slide 10: Products: Continuous Monitoring Division
Mesa’s Products Continuous Monitoring Division Markets Reporting • Pharmaceutical and Alarming Medical Device Parameter • Food and Beverage Monitoring • Hospitals • Clinics • Blood Banks Monitoring • Refrigerators • Freezers • Warehouse • Incubators • Other Equip. 10
Slide 11: Products: Biological Indicators Division
Mesa’s Products Biological Indicators Division Markets • Pharmaceutical and Medical Device Incubators • Hospitals Challenge Devices • Dental Offices Speciality Sterilization • Steam • Ethylene Oxide Spore Strips • Hydrogen Peroxide • Radiation Lab Services • Dry Heat Self-Contained 11
Slide 12: Products: Cold Chain Division
Mesa’s Products Cold Chain Division Markets • Pharmaceutical and Medical Device Consulting Services • Food and Beverage • Blood Banks Qualified Packaging Cold Chain Monitoring 12
Slide 13: Financial Summary: Revenues
Financial Summary Revenues $70,000 $60,000 $50,000 Revenues ($000) $40,000 $30,000 $20,000 $10,000 $- 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 FYE – March 31 13
Slide 14: Financial Summary: Earnings
Financial Summary Earnings $14,000 $12,000 $10,000 Income ($000) $8,000 $6,000 $4,000 $2,000 $- 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 FYE – March 31 Net Income Adjusted Net income 14
Slide 15: Earnings per Share and Dividends
Financial Summary Earnings per Share and Dividends $3.50 Regular Dividend $3.00 Net Income per Share Adj. Net Income per Share $2.50 $2.00 $1.50 $1.00 $0.50 $- 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 15 FYE – March 31
Slide 16: Comparison of 10 Year Total Shareholder Return
| Summary Comparison of “10 Year Total Shareholder Return inancia MesaLabs Fj $1,300 S&P 500 —-MLAB $1,200 $1,100 $1,000 $900 $800 $700 $600 $500 $400 $300 $200 $100 $0 ST0z/T/L ST0z/t/y ST0¢/T/T vt0z/T/OT vl0z/T/L vl0z/T/y vt0z/T/T €102/T/OT €102/T/L e10z/T/y €102/T/T 7102/T/OT 2102/T/L 2102/T/y z1
Slide 17: Latest News: Infitrak Acquisition
Latest News Infitrak Acquisition Blood/Cell/Tissue Supply Chain Cold Chain products Toronto, Ontario ~15 employees ~$5.5M revenues Yr-1 Pharma Commercial Supply Chain 17
Slide 18: Latest News: North Bay Bioscience Acquisition
Latest News North Bay Bioscience Acquisition Traverse City, MI ~35 employees Adds ~$4M in revenues in year 1 Mail-in dental sterilizer testing services Unique on-line sterilizer “management” system 18
Slide 19: Questions??
Questions?? Key Contacts: John Sullivan, President and CEO John Sakys, VP Finance and CFO InvestorRelations@mesalabs.com Phone – 303-987-8000 19
Mesa Laboratories — Investor Presentation (August 2015) on 6ix